mazindol has been researched along with Craniopharyngioma in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Craniopharyngioma: A benign pituitary-region neoplasm that originates from Rathke's pouch. The two major histologic and clinical subtypes are adamantinous (or classical) craniopharyngioma and papillary craniopharyngioma. The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations. (From Joynt, Clinical Neurology, 1998, Ch14, p50)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sadatomo, T | 1 |
Sakoda, K | 1 |
Yamanaka, M | 1 |
Kutsuna, M | 1 |
Kurisu, K | 1 |
1 other study available for mazindol and Craniopharyngioma
Article | Year |
---|---|
Mazindol administration improved hyperphagia after surgery for craniopharyngioma--case report.
Topics: Appetite Depressants; Craniopharyngioma; Humans; Hyperphagia; Male; Mazindol; Middle Aged; Postopera | 2001 |